Valuation : Tasly Pharmaceutical Group Co., Ltd

Market Cap 2.19TCr 326.16Cr 280.83Cr 263.69Cr 240.7Cr 452.18Cr 31TCr 455.42Cr 3.12TCr 1.22TCr 16TCr 1.22TCr 1.2TCr 52TCr P/E 2026 *
16x
P/E 2027 * 13.3x
Enterprise Value 2.04TCr 303.2Cr 261.06Cr 245.12Cr 223.76Cr 420.35Cr 29TCr 423.36Cr 2.9TCr 1.13TCr 15TCr 1.14TCr 1.11TCr 48TCr EV / Sales 2026 *
2.38x
EV / Sales 2027 * 1.74x
Free-Float
47.11%
Yield 2026 *
2.81%
Yield 2027 * 3.52%
1 day-1.41%
1 week-1.94%
Current month-8.93%
1 month-7.56%
3 months+4.34%
6 months+2.73%
Current year-2.59%
1 week 14.59
Extreme 14.59
15.04
1 month 14.59
Extreme 14.59
16.22
Current year 12.9
Extreme 12.9
16.24
1 year 12.9
Extreme 12.9
16.72
3 years 12.24
Extreme 12.24
18
5 years 9.2
Extreme 9.2
18
10 years 9.2
Extreme 9.2
34.22
Manager TitleAgeSince
Chief Executive Officer 54 08/05/2024
Director of Finance/CFO 49 09/07/2018
Chief Investment Officer 45 01/05/2025
Director TitleAgeSince
Director/Board Member 72 02/06/2021
Chairman 54 10/08/2026
Director/Board Member 58 08/05/2024
Change 5-day change 1-year change 3-year change Capi.($)
-1.41%-1.94%-11.14%+5.99% 330.63Cr
+0.78%+2.15%-12.49%-6.96% 1.33TCr
-2.41%+0.50%-33.04%-56.86% 499.01Cr
-3.11%-1.57%-8.27%-7.32% 465.93Cr
-1.55%-3.16%-2.75%-31.25% 401.78Cr
-1.07%+1.95%-21.84%+3.65% 359.48Cr
+3.31%+6.11%+0.23%-0.92% 343.15Cr
-1.65%-3.87%-23.53%-14.45% 237.78Cr
-1.52%+1.41%-27.89%-15.73% 172.3Cr
-1.33%+2.78%-1.99%-14.29% 169.68Cr
Average -1.00%-0.02%-14.27%-13.81% 430.57Cr
Weighted average by Cap. -0.66%-0.06%-13.98%-13.74%

Financials

2026 *2027 *
Net sales 856.18Cr 127.33Cr 109.63Cr 102.94Cr 94Cr 176.53Cr 12TCr 177.79Cr 1.22TCr 474.61Cr 6.14TCr 478.09Cr 467.7Cr 20TCr 932.08Cr 138.62Cr 119.35Cr 112.07Cr 102.3Cr 192.18Cr 13TCr 193.55Cr 1.33TCr 516.68Cr 6.69TCr 520.48Cr 509.16Cr 22TCr
Net income 137.35Cr 20Cr 18Cr 17Cr 15Cr 28Cr 1.94TCr 29Cr 195.69Cr 76Cr 985.58Cr 77Cr 75Cr 3.26TCr 165.25Cr 25Cr 21Cr 20Cr 18Cr 34Cr 2.34TCr 34Cr 235.44Cr 92Cr 1.19TCr 92Cr 90Cr 3.93TCr
Net Debt -154.39Cr -23Cr -20Cr -19Cr -17Cr -32Cr -2.18TCr -32Cr -219.96Cr -86Cr -1.11TCr -86Cr -84Cr -3.67TCr -571.22Cr -85Cr -73Cr -69Cr -63Cr -117.77Cr -8.08TCr -118.62Cr -813.83Cr -316.64Cr -4.1TCr -318.97Cr -312.04Cr -14TCr
Logo Tasly Pharmaceutical Group Co., Ltd
Tasly Pharmaceutical Group Co Ltd is a China-based company principally engaged in the manufacture and distribution of pharmaceutical products. The Company's main businesses include the manufacture and sales of traditional Chinese medicines, chemical preparations, chemical raw materials and biological medicines. The Company's main products include Compound Danshen Dropping Pills, Yangxuenao Granules, Yangxuenao Pills, Qishen Yiqi Dropping Pills, Diqing and Shuilinjia. Its products are used to treat cardiovascular and cerebrovascular diseases, tumors, colds, fevers and liver diseases. The Company mainly distributes its products in the domestic market.
Employees
10,563
Date Price Change Volume
31/26/31 CN¥14.68 -1.41% 1,62,19,530
28/26/28 CN¥14.89 +0.47% 1,52,63,887
27/26/27 CN¥14.82 +0.34% 1,35,96,225
26/26/26 CN¥14.77 +0.14% 1,37,77,567
25/26/25 CN¥14.75 -0.47% 1,24,37,989
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
4
Last Close Price
14.89CNY
Average target price
16.93CNY
Spread / Average Target
+13.72%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 600535 Stock